ICBI startup company, Anagin received $3 million NIHM grant for a new PTSD Medication
A $3 million NIHM grant provides support for a new PTSD Medication Part 2 of a series tracking the development of a safer, new PTSD… Read Now
A $3 million NIHM grant provides support for a new PTSD Medication Part 2 of a series tracking the development of a safer, new PTSD… Read Now
Theratome Bio said it plans to begin manufacturing small doses of the experimental drug and start clinical trials on patients in the first half of 2019. The plan is to administer the drugs to 24 patients who are undergoing a transaortic valve replacement, a minimally invasive surgical procedure that repairs the valve. Brain injury is … Read more
On Wednesday, November 1, 2017, several of IUPUI’S distinguished faculty scholars will showcase their translational research and illustrate how they improve people’s lives at the IUPUI TRIP Community Showcase in the IUPUI Campus Center. These scholars have partnered with community members and others to translate their research into viable practices that improve our communities. Mark … Read more
You are invited to the “Invention to Startup forum” at The Indiana Center of Biomedical Innovation (ICBI). The goal of the program is to support the advancement of translational research and lab discoveries into market-directed healthcare applications. The program is designed to provide guidance and mentorship to academic scientists. The next forum meeting is on October 27th , see information below. … Read more
The ICBI engaged local representatives from the medtech industry, like pharma giant Eli Lilly(NYSE: LLY) and Roche Diagnostics, to be part of its advisory council, which also includes experts in the legal, regulatory, and financial aspects of developing a biomedical startup. Industry reps will offer perspective on what kinds of needs are unfulfilled and meet with young startups … Read more
APPLICATIONS DUE TODAY I-CORPS Training • When: Oct. 19-20 and Nov. 17 • Where: HITS building at IUPUI • Summary: The “Introduction to Customer Discovery” course is a medical- and healthcare-focused program to help researchers and clinicians discover the commercial potential of their innovations. Apply by Sept. 22: AWARE Commercialization and Entrepreneurship Summit • When: … Read more
Allinaire Therapeutics has been awarded a $1,670,000 Phase II SBIR grant from the National Heart, Lung, and Blood Institute (NHLBI) and a $213,000 Discovery Award from the department of Defence (DOD). Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases. It is based on discoveries and intellectual property … Read more
Monon Bioventures LLC is working with Dr. Karl Koehler from the Indiana University School of Medicine on a so-called “ear-in-a-dish.” Koehler says the stem cell technology will allow scientists to better study the inner ear and the development of hearing loss. During an interview after winning Scientific Breakthrough of the Year at the 2016 Mira … Read more
Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases. Allinaire Therapeutics is based on discoveries and intellectual property from the Indiana University School of Medicine, developed by scientific founders Irina Petrache, MD and Matthias Clauss, PhD. Dr. Petrache is currently the Chief of Pulmonary, Critical Care, and Sleep … Read more
On October 31, 2016, Dr. Vincent Groppi, Director of Center for Discovery of New Medicines (CDNM), University of Michigan, presented a seminar on “ Innovative Strategies for Accelerating Academic Drug Discovery”. The seminar was sponsored by CTSI and ICBI as a part of the Translational Research and Entrepreneurship Program. Dr. Groppi discussed the innovative model that CDNM is pursuing to identify … Read more